ETF Managers Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,588
| Closed | -$473K | – | 774 |
|
|
2022
Q1 | $473K | Buy |
+10,588
| New | +$473K | 0.01% | 482 |
|
|
2021
Q2 | – | Sell |
-9,843
| Closed | -$383K | – | 671 |
|
|
2021
Q1 | $383K | Buy |
9,843
+1,323
| +16% | +$51.5K | 0.01% | 545 |
|
|
2020
Q4 | $303K | Buy |
8,520
+756
| +10% | +$26.9K | 0.01% | 543 |
|
|
2020
Q3 | $293K | Buy |
7,764
+385
| +5% | +$14.5K | 0.01% | 487 |
|
|
2020
Q2 | $256K | Buy |
7,379
+199
| +3% | +$6.9K | 0.01% | 501 |
|
|
2020
Q1 | $227K | Buy |
7,180
+736
| +11% | +$23.3K | 0.01% | 413 |
|
|
2019
Q4 | $290K | Buy |
6,444
+1,487
| +30% | +$66.9K | 0.01% | 405 |
|
|
2019
Q3 | $200K | Sell |
4,957
-130
| -3% | -$5.25K | 0.01% | 423 |
|
|
2019
Q2 | $213K | Sell |
5,087
-152
| -3% | -$6.36K | 0.01% | 351 |
|
|
2019
Q1 | $201K | Buy |
5,239
+404
| +8% | +$15.5K | 0.01% | 302 |
|
|
2018
Q4 | $171K | Buy |
4,835
+712
| +17% | +$25.2K | 0.01% | 302 |
|
|
2018
Q3 | $159K | Buy |
4,123
+434
| +12% | +$16.7K | 0.01% | 262 |
|
|
2018
Q2 | $70 | Buy |
3,689
+866
| +31% | +$16 | 0.01% | 353 |
|
|
2018
Q1 | $76K | Buy |
2,823
+352
| +14% | +$9.48K | ﹤0.01% | 398 |
|
|
2017
Q4 | $62K | Buy |
2,471
+352
| +17% | +$8.83K | ﹤0.01% | 461 |
|
|
2017
Q3 | $62K | Buy |
2,119
+190
| +10% | +$5.56K | 0.01% | 230 |
|
|
2017
Q2 | $53K | Buy |
+1,929
| New | +$53K | ﹤0.01% | 284 |
|